ABSORB [BVS]
ABSORB [BVS] is a medical device with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Absorb IV Randomized Controlled Trial
ABSORB III Randomized Controlled Trial (RCT)
PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial.
AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population
Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial
Clinical Trials (10)
Absorb IV Randomized Controlled Trial
ABSORB III Randomized Controlled Trial (RCT)
PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial.
AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population
Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial
To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels
ABSORB EXTEND Clinical Investigation
Bifurcation ABSORB OCT Trial
ABSORB Post-Approval Clinical Study
Test Efficacy With Bioresorbable Polymer Coating Versus Bioresorbable Polymer Backbone (ISAR-RESORB)
All 10 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 10